OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $265.4 million versus the consensus estimate of $201.97 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.